Could oral antiviral pills be a game-changer for COVID-19? An infectious disease physician explains why these options are badly needed
Merck and Pfizer both have oral antiviral pills under review by the FDA. Such treatments could help turn the tide of the pandemic.
Patrick Jackson, Assistant Professor of Infectious Diseases, University of Virginia •
conversation
Nov. 19, 2021 • ~9 min
Nov. 19, 2021 • ~9 min
Air filter significantly reduces presence of airborne SARS-CoV-2 in COVID-19 wards
When a team of doctors, scientists and engineers at Addenbrooke’s Hospital and the University of Cambridge placed an air filtration machine in COVID-19 wards,
Cambridge University News •
cambridge
Nov. 16, 2021 • ~6 min
Nov. 16, 2021 • ~6 min
The FDA authorizes Pfizer's COVID-19 vaccine for children ages 5 to 11 – a pediatrician explains how the drug was tested for safety and efficacy
Pediatric clinical trials for the COVID-19 Pfizer vaccine for children ages 5 to 11 have shown that the Pfizer shot is safe and effective.
Debbie-Ann Shirley, Associate Professor of Pediatrics, University of Virginia •
conversation
Oct. 29, 2021 • ~10 min
Oct. 29, 2021 • ~10 min
/
42